Is there a rationale for the prophylactic prescription of hematopoietic colony-stimulating factor after a bacteriologically documented neutropenic infection?
作者:
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细菌感染(Bacterial Infections);发热(Fever);法国(France);造血细胞生长因子(Hematopoietic Cell Growth Factors);人类(Humans);免疫减弱宿主(Immunocompromised Host);发病率(Incidence);肿瘤(Neoplasms);中性粒细胞减少(Neutropenia);回顾性研究(Retrospective Studies);脓毒症(Sepsis)
DOI
10.3109/08880019609030861
PMID
10897821
发布时间
2019-10-25
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文